{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:01:33Z","timestamp":1785772893326,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.nut.2024.112466","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T05:39:21Z","timestamp":1712468361000},"page":"112466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Does the ratio of eicosapentaenoic acid to docosahexaenoic acid matter in cancer treatment? A systematic review of their effects on cachexia-related inflammation"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8386-3562","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Szlendak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-6641","authenticated-orcid":false,"given":"Aleksandra","family":"Kapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.nut.2024.112466_bib0001","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.3390\/ijms241310717","article-title":"DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases","volume":"24","author":"Kousparou","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-015-0571-6","article-title":"Omega-3 fatty acids for breast cancer prevention and survivorship","volume":"17","author":"Fabian","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0003","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2024.112466_bib0006","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2018.12.001","article-title":"New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids","volume":"196","author":"Gorjao","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.nut.2024.112466_bib0007","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/156652411796268740","article-title":"Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis","volume":"11","author":"Wang","year":"2011","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0008","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctrv.2012.07.001","article-title":"Selective sensitization of tumors to chemotherapy by marine-derived lipids: a review","volume":"39","author":"Hajjaji","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/nu11050945","article-title":"Protective effects of omega-3 fatty acids in cancer-related complications","volume":"11","author":"Freitas","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.nut.2024.112466_bib0010","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/1389450122666210901121935","article-title":"Omega-3 fatty acid treatment combined with chemotherapy to prevent toxicity, drug resistance, and metastasis in cancer","volume":"23","author":"Soni","year":"2022","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"N-3 fatty acids, cancer and cachexia: a systematic review of the literature","volume":"97","author":"Colomer","year":"2007","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.nut.2024.112466_bib0012","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/10408398.2013.850060","article-title":"Long-chain n-3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans?","volume":"57","author":"Fasano","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.nut.2024.112466_bib0013","first-page":"2815","article-title":"Nutrition and allergies (NDA); scientific opinion related to the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)","volume":"10","year":"2012","journal-title":"EFSA J"},{"issue":"26","key":"10.1016\/j.nut.2024.112466_bib0014","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.2174\/092986711796957310","article-title":"Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved","volume":"18","author":"Serini","year":"2011","journal-title":"Curr Med Chem"},{"issue":"12","key":"10.1016\/j.nut.2024.112466_bib0015","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.3390\/nu12123718","article-title":"Do eicosapentaenoic acid and docosahexaenoic acid have the potential to compete against each other?","volume":"12","author":"Pal","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2024.112466_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2021.102662","article-title":"The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: a meta-regression of randomized clinical trials","volume":"57","author":"AbuMweis","year":"2021","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.nut.2024.112466_bib0017","series-title":"Evidence-Based Obstetric Anesthesia","first-page":"237","article-title":"Appendix: Jadad scale for reporting randomized controlled trials","author":"Halpern","year":"2005"},{"issue":"7","key":"10.1016\/j.nut.2024.112466_bib0018","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.clnu.2019.09.009","article-title":"A double-blind randomized controlled trial of the effects of eicosapentaenoic acid supplementation on muscle inflammation and physical function in patients undergoing colorectal cancer resection","volume":"39","author":"Hossain","year":"2020","journal-title":"Clin Nutr"},{"issue":"21","key":"10.1016\/j.nut.2024.112466_bib0019","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.nut.2024.112466_bib0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hed.25987","article-title":"Efficacy of EPA-enriched supplement compared with standard formula on body weight changes in malnourished patients with head and neck cancer undergone surgery: a randomized study","volume":"42","author":"Jantharapattana","year":"2020","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.nut.2024.112466_bib0021","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.nut.2024.112466_bib0022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clnesp.2019.06.003","article-title":"The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: prospective randomized control study","volume":"33","author":"Akita","year":"2019","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"10.1016\/j.nut.2024.112466_bib0023","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/01635581.2018.1460678","article-title":"Effect of eicosapentaenoic acid on body composition and inflammation markers in patients with head and neck squamous cell cancer from a public hospital in Mexico","volume":"70","author":"Sol\u00eds-Mart\u00ednez","year":"2018","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.nut.2024.112466_bib0024","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/01635581.2017.1274406","article-title":"Effect of Nutritional supplementation enriched with eicosapentaenoic acid on inflammatory profile of patients with oral cavity cancer in antineoplastic pretreatment: a controlled and randomized clinical trial","volume":"69","author":"Carvalho","year":"2017","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.nut.2024.112466_bib0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clnu.2014.03.006","article-title":"Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial","volume":"33","author":"S\u00e1nchez-Lara","year":"2014","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.nut.2024.112466_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SLA.0b013e31819a4789","article-title":"Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial","volume":"249","author":"Ryan","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0027","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01635581.2020.1871495","article-title":"Randomized phase II Study of Gemcitabine Monotherapy vs. gemcitabine with an epa-enriched oral supplement in advanced pancreatic cancer","volume":"74","author":"Ueno","year":"2022","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.nut.2024.112466_bib0028","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ejcn.2011.214","article-title":"Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT","volume":"66","author":"van der Meij","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nut.2024.112466_bib0029","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clnesp.2021.03.001","article-title":"N-3 fatty acid EPA supplementation in cancer patients receiving abdominal radiotherapy: a randomised controlled trial","volume":"43","author":"Patursson","year":"2021","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"10.1016\/j.nut.2024.112466_bib0030","first-page":"769","article-title":"Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial","volume":"36","author":"de la Rosa Oliva","year":"2019","journal-title":"Nutr Hosp"},{"issue":"3","key":"10.1016\/j.nut.2024.112466_bib0031","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clnu.2012.09.009","article-title":"Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial","volume":"32","author":"Faber","year":"2013","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.nut.2024.112466_bib0032","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11745-013-3816-0","article-title":"Fish oil decreases C-reactive protein\/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients","volume":"48","author":"Mocellin","year":"2013","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.nut.2024.112466_bib0033","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0007114511005551","article-title":"Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study","volume":"108","author":"Finocchiaro","year":"2012","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12937-017-0295-9","article-title":"The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment na\u00efve breast cancer patients: a randomized double-blind controlled trial","volume":"16","author":"Paix\u00e3o","year":"2017","journal-title":"Nutr J"},{"issue":"2","key":"10.1016\/j.nut.2024.112466_bib0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcn\/nqz281","article-title":"Effects of perioperative intravenous \u03c9-3 fatty acids in colon cancer patients: a randomized, double-blind, placebo-controlled clinical trial","volume":"111","author":"Bakker","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.nut.2024.112466_bib0036","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.clnu.2022.03.018","article-title":"Effects of EN combined with PN enriched with n-3 polyunsaturated fatty acids on immune related indicators and early rehabilitation of patients with gastric cancer: a randomized controlled trial","volume":"41","author":"Yang","year":"2022","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.nut.2024.112466_bib0037","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/19390211.2019.1600096","article-title":"Randomized study of the effect of vitamin D and omega-3 fatty acids cosupplementation as adjuvant chemotherapy on inflammation and nutritional status in colorectal cancer patients","volume":"17","author":"Haidari","year":"2020","journal-title":"J Diet Suppl"},{"issue":"8","key":"10.1016\/j.nut.2024.112466_bib0038","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3945\/jn.113.174383","article-title":"n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women","volume":"143","author":"Kratz","year":"2013","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.nut.2024.112466_bib0039","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3945\/ajcn.116.148114","article-title":"Very-long-chain \u03c9-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial","volume":"105","author":"Hames","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/fca-2020-0106","article-title":"Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction","volume":"17","author":"Boden","year":"2021","journal-title":"Future Cardiol"},{"issue":"19","key":"10.1016\/j.nut.2024.112466_bib0041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013543","article-title":"Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants","volume":"8","author":"Hu","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.nut.2024.112466_bib0042","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/wps.20672","article-title":"The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Firth","year":"2019","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0043","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"11","key":"10.1016\/j.nut.2024.112466_bib0044","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/md10112535","article-title":"Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids","volume":"10","author":"Russell","year":"2012","journal-title":"Mar Drugs"},{"key":"10.1016\/j.nut.2024.112466_bib0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.freeradbiomed.2017.09.002","article-title":"Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma","volume":"112","author":"Ou","year":"2017","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.plefa.2009.05.018","article-title":"Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women","volume":"81","author":"Metherel","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"27","key":"10.1016\/j.nut.2024.112466_bib0047","doi-asserted-by":"crossref","first-page":"19412","DOI":"10.1016\/S0021-9258(18)41791-7","article-title":"Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process","volume":"267","author":"Connor","year":"1992","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0048","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2012.03.008","article-title":"Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids","volume":"88","author":"Turk","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"9","key":"10.1016\/j.nut.2024.112466_bib0049","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000137191.02577.86","article-title":"Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway","volume":"24","author":"Mishra","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.nut.2024.112466_bib0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.coph.2009.06.020","article-title":"Inflammation and cancer: how friendly is the relationship for cancer patients?","volume":"9","author":"Aggarwal","year":"2009","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0051","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","article-title":"Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes","volume":"81","author":"Greenlee","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0052","doi-asserted-by":"crossref","first-page":"e13167","DOI":"10.1111\/cpr.13167","article-title":"Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis","volume":"55","author":"Li","year":"2022","journal-title":"Cell Prolif"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0053","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1194\/jlr.TR119000439","article-title":"Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy: thematic review series: biology of lipid rafts","volume":"61","author":"Mollinedo","year":"2020","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.nut.2024.112466_bib0054","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/ijms18122770","article-title":"\u03c9-3 long chain polyunsaturated fatty acids as sensitizing agents and multidrug resistance revertants in cancer therapy","volume":"18","author":"Corsetto","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0055","first-page":"1103","article-title":"Cholesterol metabolism in drug\u2011resistant cancer (Review)","volume":"57","author":"Yan","year":"2020","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nut.2024.112466_bib0056","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1476-4598-12-137","article-title":"Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition","volume":"12","author":"Gelsomino","year":"2013","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.nut.2024.112466_bib0057","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00394-015-1053-4","article-title":"Understanding the cholesterol metabolism-perturbing effects of docosahexaenoic acid by gas chromatography-mass spectrometry targeted metabonomic profiling","volume":"56","author":"Bahety","year":"2017","journal-title":"Eur J Nutr"},{"issue":"10","key":"10.1016\/j.nut.2024.112466_bib0058","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.bbagen.2014.07.003","article-title":"A Fourier transform infrared spectroscopy study of cell membrane domain modifications induced by docosahexaenoic acid","volume":"1840","author":"Mereghetti","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.nut.2024.112466_bib0059","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/sj.bjc.6605441","article-title":"Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial","volume":"101","author":"Bougnoux","year":"2009","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.nut.2024.112466_bib0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/01635580903532366","article-title":"DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells","volume":"62","author":"Slagsvold","year":"2010","journal-title":"Nutr Cancer"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900724001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900724001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T06:17:10Z","timestamp":1718432230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900724001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":60,"alternative-id":["S0899900724001163"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2024.112466","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the ratio of eicosapentaenoic acid to docosahexaenoic acid matter in cancer treatment? A systematic review of their effects on cachexia-related inflammation","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2024.112466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112466"}}